Frank H. Valone
Overview
Frank H. Valone received an average of $2M in total compensation, including $396K in salary, at FibroGen from 2013 to 2016.
2016FibroGenSenior Fellow, Clinical Development formerly Chief Medical Officer
2015FibroGenSenior Fellow, Clinical Development formerly Chief Medical Officer
2014FibroGenSenior Fellow, Clinical Development formerly Chief Medical Officer
2013FibroGenSenior Fellow, Clinical Development formerly Chief Medical Officer
Source: SEC filings on April 24, 2017 and April 22, 2016.
Related executives
We found ten more executives who work or worked at FibroGen.
Enrique Conterno
FibroGen
Chief Executive Officer
Christine Chung
FibroGen
Senior Vice President, China Operations
Mark Eisner
FibroGen
Chief Medical Officer
Pat Cotroneo
FibroGen
Chief Financial Officer
Elias Kouchakji
FibroGen
Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance
Thane Wettig
FibroGen
Chief Commercial Officer
Juan Graham
FibroGen
Chief Financial Officer
K Yu
FibroGen